HKU: New Discovery for COVID-19

SCMP: Hong Kong researchers find common ulcer drug could be effective in halting coronavirus replication in patients

• Researchers say the drug could be as effective as the new Covid-19 drug remdesivir, which is currently in short supply amid the pandemic
  
  
• The medication, which contains the metal bismuth, works by interrupting the process by which the virus replicates inside cells
  
  
• A University of Hong Kong study has found that ranitidine bismuth citrate, or RBC, a drug commonly used to treat stomach ulcers, shows promise in preventing the SARS-CoV-2 coronavirus from replicating in an animal model. The researchers said RBC's effectiveness is comparable to the outcome of the coronavirus drug remdesivir, but at a much lower cost.

Nature Microbiology:
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters

Please Note:

In September 2019, the carcinogen N-nitrosodimethylamine (NDMA) was discovered in ranitidine products from a number of manufacturers, resulting in recalls. In April 2020, it was withdrawn from the United States market and suspended in the European Union and Australia due to these concerns. Wikipedia

You May Like: 

Death Valley, Mohave 莫哈維沙漠

Romantic Danube 華沙 - 慕尼黑

Provence, France 馬賽-里昂